Turnstone Biologics Corp. Common Stock

NASDAQ:TSBX USA Biotechnology

Market Cap

$8.21 Million

Market Cap Rank

#31246 Global

#10285 in USA

Share Price

$0.36

Change (1 day)

+0.00%

52-Week Range

$0.31 - $0.42

All Time High

$12.95

Turnstone Biologics Corp. Common Stock - Asset Resilience Ratio

Latest as of December 2024: 0.00%

Turnstone Biologics Corp. Common Stock (TSBX) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$40.14 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Turnstone Biologics Corp. Common Stock's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Turnstone Biologics Corp. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Turnstone Biologics Corp. Common Stock maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.